FormBlends Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: Shoppers wanting a low compounded-semaglutide entry price with lots of on-site education
FormBlends is one of the most affordable GLP-1 options on the market.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
FormBlends is a US direct-to-consumer brand selling compounded GLP-1 weight-loss medication — compounded semaglutide from $99 and compounded tirzepatide from $349 — dispensed by a licensed 503A pharmacy and fulfilled through its FormScripts telehealth portal. The product funnel sits alongside heavy educational content and an on-site provider-comparison directory. Physician-supervised, with free shipping on orders over $150.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to FormBlends
MEDVi
Best for: patients who want the option to switch between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
Liv Body
Best for: compounded GLP-1 paired with a muscle-preservation supplement stack
Editorial score · methodology
DudeMeds
Best for: men seeking no-fee GLP-1 access with oral and injectable options
Editorial score · methodology
FormBlends at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Compounded Semaglutide, Compounded Tirzepatide
- Starting price
- $99/mo (Published offer price via rx.formscripts.com; may be intro — confirm at checkout)
- What's included
- Medication · Consult
- FDA status
- No FDA warning letter on record
How we scored FormBlends
Each dimension is scored algorithmically from FormBlends’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.5/10At $99/mo, FormBlends runs about 41% below the $169 median for GLP-1 providers.
Effectiveness25%
7.5/10FormBlends offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.8/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
7.4/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-07-16).
Accessibility10%
5.5/10FormBlends's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.3/10FormBlends provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this FormBlends review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications FormBlends offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Published offer price via rx.formscripts.com; may be intro — confirm at checkout
Published offer price via rx.formscripts.com
Ready to get started?
Plans and promotions change often — check FormBlends's current pricing and active discounts before you decide.
What we like
- Low published entry price on compounded semaglutide ($99) from a licensed 503A pharmacy
- Physician-supervised program with 24/7 care-team access and free shipping over $150
- Extensive free educational content, guides and provider comparisons on-site
Watch-outs
- Enrollment and final pricing complete on an external portal (rx.formscripts.com), not fully on-site
- $99 may be an intro rate; tirzepatide is comparatively high at $349/mo
- State availability and LegitScript status not published; pharmacy is its own FormScripts brand
Is FormBlends worth it? Our verdict
FormBlends positions itself around one thing: Shoppers wanting a low compounded-semaglutide entry price with lots of on-site education. It runs $99/month — toward the affordable end of the market.
On top of the prescription itself, FormBlends points to Compounded Semaglutide, Compounded Tirzepatide, and 503A pharmacy.
How much FormBlends actually costs
- Compounded semaglutide — $99/month
- Compounded tirzepatide — $349/month
That puts FormBlends below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
For a direct comparison, Embody runs semaglutide and tirzepatide from $79/month — worth pricing against FormBlends before you commit.
Medications: what FormBlends prescribes
FormBlends prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who FormBlends is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
FormBlends dispenses through an accredited compounding pharmacy. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
FormBlends earns its place on the shortlist mainly on price: at $99/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
FormBlends is one of the most affordable GLP-1 options on the market.
Ready to start with FormBlends?
Starting at $99/month. See current pricing and start your free consultation.
FormBlends might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider MEDVi.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this FormBlends review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See FormBlends's current pricing
Plans start at $99/month. Start your free consultation to check eligibility and today's price.